• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID Back to Search Results
Model Number PC0930RXC
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Insufficient Information (4580)
Event Date 01/04/2021
Event Type  malfunction  
Manufacturer Narrative
A review of the manufacturing documentation associated with lot 17934632 presented no issues during the manufacturing process that can be related to the reported event.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.
 
Event Description
As reported, the 9mm x 30mm precise pro rapid exchange (rx) carotid stent system was implanted.After that, the physician noticed that the distal end of the device was separated.It was difficult to remove the separated part, but it was removed together when the physician removed a non-cordis filter wire.There was no patient injury reported and the procedure was completed.This was a carotid artery stenting (cas) case.The product was stored and handled according to the instructions for use (ifu).The device was prepped according to the ifu.No damages were noted to the device prior to using.There was no difficulty experienced in prepping the device.The precise pro was used as per the instructions for use (ifu).The target site was the right internal carotid artery which was 75 percent stenosed.The access site was the left femoral artery.It was verified prior to insertion that stent was contained within the outer sheath/introducer of the system.The device was not used for a chronic total occlusion (total occlusion >3 months).The device will be returned for evaluation together with non-cordis filter wire.
 
Manufacturer Narrative
A precise pro 9mm x 30mm rapid exchange (rx) carotid stent system was implanted.After that, the physician noticed that the distal end of the device was separated.It was difficult to remove the separated part, but it was removed together when the physician removed a non-cordis filter wire.This was a carotid artery stenting (cas) case.The product was stored and handled according to the instructions for use (ifu).The device was prepped according to the ifu.No damages were noted to the device prior to using.There was no difficulty experienced in prepping the device.The precise pro was used as per the instructions for use (ifu).The target site was the right internal carotid artery which was 75 percent stenosed.The access site was the left femoral artery.It was verified prior to insertion that stent was contained within the outer sheath/introducer of the system.The device was not used for a chronic total occlusion (total occlusion >3 months).There was no patient injury reported and the procedure was completed.The device was returned for analysis.Visual review: one non-sterile precise pro rx us carotid syst was received for analysis inside a plastic bag.No original packaging was returned.A non-cordis embolic protection system was received inside the same bag.Also, an unknown stopcock was observed attached to the unit.The valve of the unit was received opened.Per visual analysis, the stent of the unit was observed deployed but was not received along the unit.The wire lumen was observed separated from the distal tip.Distal tip was observed inserted into the non-cordis embolic protection system received.An acceptable adhesive quantity was observed inside the tip¿s glue port.Nevertheless, due to the condition received of the tip, visual analysis couldn¿t determine if the correct amount of adhesive was applied through the entire section between the wire lumen and the tip.No other anomalies were observed.A product history record (phr) review of lot 17934632 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter tip - separated - in patient¿ was confirmed since the distal tip was observed separated from the wire lumen.An acceptable adhesive quantity was observed inside the tip¿s glue port.Nevertheless, due to the condition received of the tip, visual analysis couldn¿t determine if the correct amount of adhesive was applied throughout the entire section between the wire lumen and the tip.After the physical evaluation of the unit, it was determined by the engineering team (pet) that the tip separation was a manufacturing related as the physical evaluation couldn¿t conclusively determine if the correct amount of adhesive was applied through the entire section between the wire lumen and the tip.According to the instructions for use, which is not intended as a mitigation of risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.¿ the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, a corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
MDR Report Key11260051
MDR Text Key230949806
Report Number9616099-2021-04219
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032036518
UDI-Public20705032036518
Combination Product (y/n)N
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2022
Device Model NumberPC0930RXC
Device Catalogue NumberPC0930RXC
Device Lot Number17934632
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/19/2021
Date Manufacturer Received03/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FILTER WIRE (BOSTON SCIENTIFIC)
Patient Age76 YR
-
-